Export 2409 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Seabra, A. R., Silva, L. S., & Carvalho, H. G. (2013). Novel aspects of glutamine synthetase (GS) regulation revealed by a detailed expression analysis of the entire GS gene family of Medicago truncatula under different physiological conditions. BMC Plant Biology, 13(1).
Seabra, A. R., & Carvalho, H. G. (2015). Glutamine synthetase in Medicago truncatula, unveiling new secrets of a very old enzyme. Frontiers in Plant Science, 6(JULY).
Seabra, A. R., Vieira, C. P., Cullimore, J. V., & Carvalho, H. G. (2010). Medicago truncatula contains a second gene encoding a plastid located glutamine synthetase exclusively expressed in developing seeds. BMC Plant Biology, 10.
Seabra, A., Katzmarzyk, P., Carvalho, M. J., Seabra, A., et al. (2016). Effects of 6-month soccer and traditional physical activity programmes on body composition, cardiometabolic risk factors, inflammatory, oxidative stress markers and cardiorespiratory fitness in obese boys. Journal of Sports Sciences, 34(19), 1822 - 1829.
Segundo, M. A., Abreu, V. L. R. G., Osório, M. V., Nogueira, S., et al. (2016). Development and validation of HPLC method with fluorometric detection for quantification of bisnaphthalimidopropyldiaminooctane in animal tissues following administration in polymeric nanoparticles. Journal of Pharmaceutical and Biomedical Analysis, 120, 290 - 296.
Seixas, A. I., Holmes, S. E., Takeshima, H., Pavlovich, A., et al. (2012). Loss of junctophilin-3 contributes to huntington disease-like 2 pathogenesis. Annals of Neurology, 71(2), 245 - 257.
Seixas, D., & Ayres Basto, M. (2008). Ethics in fMRI studies: A review of the EMBASE and MEDLINE literature. Clinical Neuroradiology, 18(2), 79 - 87.
Seixas, D., Galhardo, V., Sá, M. J., Guimarães, J., & Lima, D. (2009). Pain in multiple sclerosis: Characterization of a Portuguese population of 85 patients. Dor na esclerose múltipla: Caracterização de uma população Portuguesa de 85 doentesActa Medica Portuguesa, 22(3), 233 - 240.
Seixas, A. I., Loureiro, J. R., Costa, C., Ordóñez-Ugalde, A., et al. (2017). A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia. American Journal of Human Genetics, 101(1), 87 - 103.
Seixas, A. I., Vale, J., Jorge, P., Marques, I., et al. (2011). FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behavioral and Brain Functions, 7.
Seixas, A. I., Maurer, M. H., Lin, M., Callahan, C., et al. (2005). FXTAS, SCA10, and SCA17 in American patients with movement disorders [1]. American Journal of Medical Genetics, 136 A(1), 87 - 89.
Seixas, D., Palace, J., & Tracey, I. (2016). Chronic pain disrupts the reward circuitry in multiple sclerosis. European Journal of Neuroscience, 44(3), 1928 - 1934.
Seixas, D., & Lima, D. (2011). Accuracy, reliability, validity and limitations of functional and structural magnetic resonance imaging data. Cortex, 47(10), 1266 - 1269.
Seneca, S., Morris, M. A., Patton, S., Elles, R., & Sequeiros, J. (2008). Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias. European Journal of Human Genetics, 16(8), 913 - 920.
Sequeiros, J. (2006). Corino Andrade (1906-2005): a clinical geneticist before its own time. Clinical genetics, 69(2), 194 - 196.
Sequeiros, J., Gibbon, S., & Clarke, A. (2015). Genetics and ethics in Latin America. Journal of Community Genetics, 6(3), 185 - 187.
Sequeiros, J., Ramos, E. M., Cerqueira, J., Costa, M. C., et al. (2010). Large normal and reduced penetrance alleles in Huntington disease: Instability in families and frequency at the laboratory, at the clinic and in the population. Clinical Genetics, 78(4), 381 - 387.
Sequeiros, J., Seneca, S., & Martindale, J. (2010). Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias. European Journal of Human Genetics, 18(11), 1188 - 1195.
Sequeiros, J., Martindale, J., & Seneca, S. (2010). EMQN Best Practice Guidelines for molecular genetic testing of SCAs. European Journal of Human Genetics, 18(11), 1173 - 1176.
Sequeiros, J., Martins, S., & Silveira, I. (2011). Epidemiology and population genetics of degenerative ataxias. Handbook of Clinical Neurology (Vol. 103, pp. 227 - 251).
Sequeiros, J., Paneque, M., Guimarães, B., Rantanen, E., et al. (2012). The wide variation of definitions of genetic testing in international recommendations, guidelines and reports. Journal of Community Genetics, 3(2), 113 - 124.
Sequeiros, J., Santos, C., & Jardim, L. B. (2009). Response to Tumas et al. Clinical Genetics, 75(2), 208.
Sereno, D., Monte Alegre, A., Silvestre, R., Vergnes, B., & Ouaissi, A. (2005). In vitro antileishmanial activity of nicotinamide. Antimicrobial Agents and Chemotherapy, 49(2), 808 - 812.
Sereno, D., Cordeiro Da Silva, A., Mathieu-Daude, F., & Ouaissi, A. (2007). Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitology International, 56(1), 3 - 7.
Sereno, D., Vergnes, B., Mathieu-Daude, F., Cordeiro Da Silva, A., & Ouaissi, A. (2006). Looking for putative functions of the Leishmania cytosolic SIR2 deacetylase. Parasitology Research, 100(1), 1 - 9.


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |

rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc